Back

Emergent secures $24 million BARDA contract modification for CYFENDUS

Verifying
  • Emergent BioSolutions received a BARDA contract modification to supply CYFENDUS for anthrax preparedness.
  • The modification is valued at approximately $24 million.
  • Emergent earlier announced a BioThrax delivery order worth up to $21.5 million for the U.S. Department of War.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.